[ad_1] WASHINGTON — Maryland firm Novavax, which won a $1.75 billion federal contract to develop and manufacture a coronavirus vaccine, said Thursday that the federal government will not fund furtherRead More
[ad_1] WASHINGTON — Maryland firm Novavax, which won a $1.75 billion federal contract to develop and manufacture a coronavirus vaccine, said Thursday that the federal government will not fund furtherRead More